Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,504 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07813000Recruiting
Patient and doctor views on cell therapies for advanced cancer
This study is a survey to learn about what patients and doctors think about newer cell-based cancer treatments (like CAR-T or TIL therapy). You will answer questions about your experiences and preferences, which will help guide future research.
Hangzhou, ZhejiangAges 18 years+ - NCT07812740Recruiting
A long-term study of rare headache disorders
This study is designed to learn more about a group of rare headache disorders called trigeminal autonomic cephalalgias (TACs). If you have one of these conditions, participating could help doctors better understand how they behave over time and improve care for others like you.
Milan, MIAges 18 years+ - NCT07817147Recruiting
Microwave ablation treatment for advanced cancer
This study tests a procedure called microwave ablation (using heat to destroy cancer cells) for tumors that are hard to remove with surgery. It aims to see if the procedure is safe and effective when done through a scope in the stomach.
Gilbert, ArizonaAges 18 years+ - NCT07813377Recruiting
Blood clotting test to predict outcomes after brain tumor surgery
This study looks at a special blood test (called thromboelastography) that checks how well your blood clots. The goal is to see if this test can predict how the surgery goes and whether you might get a blood clot after surgery. If you join, the test will be done before and after your brain surgery, and you will be monitored for any blood clot complications.
BarcelonaAges 18 years+ - NCT07810933RecruitingPhase 1/Phase 2
Study of a new ALK inhibitor for advanced cancer
This trial tests a new pill, SY-12321, for people with advanced cancer that has a specific change called ALK. The study aims to see if the drug can shrink tumors or slow their growth, and it may be an option if you've already tried other ALK-targeting treatments.
Guangzhou, GuangdongAges 18 years+ - NCT07810621Recruiting
Low cardiac output after heart surgery
This study looks at how well the heart pumps right after bypass surgery and whether a special monitor can help predict problems. It may help doctors support patients better after surgery.
Ankara, AnkaraAges 18 years+ - NCT07817082RecruitingPhase 2
A new drug for her2 ultra-low advanced breast cancer
This study tests a new targeted drug (SHR-A1811) for breast cancer that has very low HER2 levels. The drug is designed to attack cancer cells with this specific marker, and the study aims to see if it can help slow the cancer's growth.
TianjinAges 18–75 - NCT07815366Enrolling by invitation
Eccentric cycling exercise for healthy adults
This study tests a special kind of exercise bike that works your muscles in a different way (called eccentric cycling) to see if it helps healthy people improve their fitness. You would ride this bike for 3 months, and the study team will check your progress.
Zurich, Canton of ZurichAges Any age - NCT07811544Enrolling by invitation
Immune system study for sepsis-related kidney injury after surgery
This study looks at how the immune system responds in patients who develop sepsis after surgery and how it relates to kidney injury. It aims to help improve care for conditions like this.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07814157Recruiting
Basel registry study on complex heart artery procedures
This study collects information on patients who have complex heart artery procedures at the University Hospital in Basel, to track how well these treatments work and how safe they are.
Basel, Canton of Basel-CityAges 18 years+ - NCT07813169Recruiting
Brain stimulation for loss of pleasure in depression
This study tests a type of brain stimulation called iTBS (repetitive magnetic pulses) to see if it can help people with depression who feel little pleasure in life. The treatment targets a brain area involved in reward, and may improve your mood and ability to enjoy things.
Changsha, HunanAges 18–45 - NCT07813559Recruiting
Using a special PET/CT scan to find blood clots
This study uses a special PET/CT scan to see blood clots in the body. The scan uses a tracer that sticks to a protein on blood clots, which might help doctors find clots that other scans miss.
Hefei, AnhuiAges 18–90 - NCT07815223RecruitingPhase 2
Immunotherapy and targeted drug after chemoradiation for limited-stage small cell lung cancer
This trial tests whether adding two medications—tislelizumab (an immunotherapy that helps your immune system fight cancer) and anlotinib (a targeted drug that blocks blood supply to tumors)—after standard chemoradiation can help keep limited-stage small cell lung cancer from coming back. It may offer a new option to improve outcomes for patients who have already responded to initial treatment.
Yantai, ShandongAges 18–75 - NCT07814456RecruitingPhase 2
Fecal transplant for ulcerative colitis comparing donor types
This trial tests fecal microbiota transplantation (a procedure that puts healthy donor bacteria into your gut) for left-sided ulcerative colitis. It compares results using donors from two different backgrounds to see if one works better.
Kunming, YunnanAges 18–60 - NCT06494371RecruitingPhase 1
Study of LCAR-HL30 for Hodgkin's and anaplastic large cell lymphoma
This trial tests a new treatment called LCAR-HL30 for people with Hodgkin's lymphoma or anaplastic large cell lymphoma that has come back or not responded to therapy. The treatment targets cells with a protein called CD30 to help your body fight the cancer.
ShanghaiAges 18–75 - NCT06312085Recruiting
Root canal study with new filling material
This study tests a new material for filling root canals after cleaning out an infection. It aims to see if the material helps the tooth heal successfully. You may qualify if you have an infected tooth that has never had a root canal before.
IstanbulAges 18–75 - NCT06199401Recruiting
Testing a new surgery for type A aortic tear
This trial tests a new surgical method (XJ-Procedure) for people with an acute tear in the upper part of the main artery from the heart (type A aortic dissection). It may offer a safer option for those needing 'Sun's procedure' surgery.
Xi'an, ShaanxiAges 18–70 - NCT06478576Recruiting
Study of a new stent graft for thoracoabdominal aortic aneurysm
This trial tests a new multibranched stent graft system to treat thoracoabdominal aortic aneurysms. It may help patients who have an aneurysm that is large, growing quickly, or causing symptoms like pain.
BeijingAges 18–80 - NCT06501950Recruiting
Measuring silent MS progression with advanced tests
This study is looking for people with MS who are already on a monoclonal antibody therapy. It aims to measure subtle signs of disease progression using advanced tests, even if you feel stable.
Düsseldorf, North Rhine-WestphaliaAges 18 years+ - NCT06498947Recruiting
Understanding Natural Farsightedness in Kids
This study looks at natural changes in children's eyes that cause mild farsightedness (called "physiological hyperopia") in 6- to 9-year-olds. It aims to understand why some children have this harmless vision difference, which may help with future eye care.
Beijing, Beijing MunicipalityAges 6–9 - NCT05159245RecruitingPhase 2
Targeted drug access for adults with advanced cancer
This trial helps match people with advanced, hard-to-treat cancers to targeted cancer drugs based on lab testing of their tumor. It may help if standard treatment isn’t working or isn’t available, and if your tumor has a “targetable” genetic change.
Turku, Southwest FinlandAges 18–100 - NCT05042219Recruiting
How lung disease treatment may affect heart function
This study looks at how common long-term lung conditions and their treatments may change heart function. It uses heart imaging (an MRI) to see what’s happening, which could help doctors better monitor heart risks in people with lung disease.
AachenAges 18–99 - NCT06500403Recruiting
Non-invasive tools for liver injury after chemotherapy
This study tests non-invasive methods to diagnose a liver condition called PSVD in people who have received platinum chemotherapy. It may help find liver problems early without a biopsy.
Guangzhou, GuangdongAges 18–80 - NCT05979155RecruitingPhase 1
Study of NWY001 for advanced solid tumors
This study tests a new experimental drug (NWY001) for people with advanced solid tumors that have stopped responding to standard treatments. It is a phase 1 trial, meaning it is early research to find the right dose and check for side effects.
Guangzhou, GuangdongAges 18–75
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,504 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.